ReviewInternational journal of clinical oncology2024

Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution.

Atsunari Kawashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.